Foot and Ankle / Achilles Tendon Disorders / PRP / VAS+VISA-A

This Circle helps physicians capture and monetize real-world data from their everyday delivery of PRP for Achilles Tendinitis.  

The Platelet Rich Plasma “PRP” Market is valued at 828.8 Billion in 2023, and is estimated to grow to over 3 Trillion by 2032. Achilles Tendon Disorders are among the most common types of tendinopathies. Achilles Tendon Disorders are fairly common in the general population, affecting around 1-2% of individuals overall. The prevalence is significantly higher in athletes, especially those who participate in high-impact sports. For individuals over the age of 40, Achilles Tendon Disorders are more prevalent due to degenerative changes. Manufacturers will thus increasingly spend on obtaining and maintaining regulatory approvals for marketing those products for Achilles Tendon Disorders. Increasingly, that spending will be focused on licensing real-world safety and efficacy data from their everyday customers.

This Circle helps physicians obtain and aggregate those high quality real-world data those companies are looking for. Participation is minimally burdensome, and members will receive recurring license fees once obtained and in accordance with their contribution of Achilles Tendinitis cases, outcomes and other case data.